Safeway joins the $4 per month US generic Rx sale

15 June 2008

US grocery firm Safeway has announced the launch of a $4 per month supply of generic prescription medicines on hundreds of copy drugs, nearly two years after the world's biggest retailer, Wal-Mart, opened a price war with its low cost program (Marketletters passim). The medicines available under the new marketing campaign include the antibiotic amoxicillin, atenolol for hypertension and levothyroxine for thyroid disease.

Safeway spokesman Greg TenEyck told the Washington Post: "we've been reacting to the competitive marketplace." A few weeks ago, Wal-Mart extended its own $4 per month scheme as well as a $9 rate for more expensive products. Another major retailer, Target, has matched Wal-Mart's offers. Other firms, including pharmacy chains, are offering various forms of discounts, including free antibiotics and seasonal influenza innoculations.

The Safeway campaign was trialled at stores in Houston and Dallas, Texas, in March before being officially launched in the District of Columbia and the neigboring states of Virginia, Maryland, Delaware and New Jersey. In the Washington DC area, there are in-store pharmacies at 83 of the retailer's 110 outlets. The Post also reported that Safeway units in the midwestern Chicago, Illinois, area are carrying discounted prescriptions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight